# Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

> **NCT05748990** · NA · RECRUITING · sponsor: **Centre for Addiction and Mental Health** · enrollment: 20 (estimated)

## Conditions studied

- Schizophrenia
- Healthy

## Interventions

- **DRUG:** Intranasal insulin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05748990
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05748990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05748990, "Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05748990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*